Anti-COVID-19 pill may be available in PH starting November | Inquirer News
Close  

Anti-COVID-19 pill may be available in PH starting November

/ 06:39 PM October 13, 2021

MANILA, Philippines — The first oral drug clinically proven to reduce the risk of hospitalization and death from COVID-19 may arrive in the country next month.

This was announced by Faberco Life Sciences Inc., which was appointed to distribute the Molnupiravir 200mg capsule in the Philippines by Aurobindo Pharma Ltd., a partner manufacturer of Merck & Co, the developer of the said drug.

ADVERTISEMENT

Faberco said it also partnered with RiteMed Philippines, Inc. in the distribution of the anti-COVID oral drug to hospitals, medical institutions, and treatment sites once compassionate special permits (CSP) are filed with and approved by the Philippine Food and Drug Administration (PFDA).

“We are confident that through the distribution channels of RiteMed, Molnupiravir will reach healthcare facilities throughout the country faster, giving more Filipinos access to this lifesaving drug the soonest possible time,” said Kishore Hemlani, founder of Faberco.

FEATURED STORIES

“This partnership with Faberco puts RiteMed in a good position to help more Filipinos survive the pandemic and is aligned with our mission to provide access to essential medicines by partnering with like-minded doctors and healthcare facilities,” said RiteMed president Jose Maria Ochave.

Food and Drug Administration Director-General Eric Domingo earlier said that the oral antiviral drug can be used by doctors in hospitals for COVID treatment through the CSP.

Department of Health (DOH) Undersecretary Maria Rosario Vergeire also earlier promised that it will make efforts to “have better access” to the antiviral pill.

RELATED STORIES

Merck pill breakthrough raises hopes of preventing COVID deaths

Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19

Merck says deal signed with Singapore on COVID-19 antiviral pill

je

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: antiviral pill, COVID-19, DoH, Health, Merck, molnupiravir, treatment
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.